All In MedTech

FDA Clearance Tracker · K201892

Ritleng®+ and Ritleng®+ PVP

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Mar 11, 2021 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Mar 11, 2021

Substantially Equivalent

Time to decision

246 days

Received Jul 8, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Unclassified

The decision

FDA number
K201892
Device name
Ritleng®+ and Ritleng®+ PVP
Applicant location
Paris, FR
Received
Jul 8, 2020
Decided
Mar 11, 2021
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Unclassified
Specialty
Ophthalmology

Every decision under product code OKS

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code OKS. The earliest in FDA's data is K883233, decided Aug 22, 1988.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Fci (France Chirurgie Instrumentation) Sas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.